Gynesonics
Gynesonics developed the Sonata System, an incisionless transcervical radiofrequency ablation device for treating uterine fibroids and heavy menstrual bleeding. The Redwood City, California medical device company was acquired by Hologic in October 2024 for approximately $350 million.
- Company typePrivate
- Founded2005
- HeadquartersRedwood City, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Gynesonics does
Gynesonics is a medical device company founded in 2005 and headquartered in Redwood City, California, that developed the Sonata System, an incisionless transcervical radiofrequency ablation platform for the treatment of symptomatic uterine fibroids and heavy menstrual bleeding. The system uses intrauterine ultrasound guidance to target and ablate fibroids without surgical incision, positioning it as a minimally invasive alternative to traditional hysterectomy or myomectomy procedures. The company operated as a single-product, vertically focused medtech firm, selling its hardware to hospitals, outpatient surgery centers, and gynecology clinics through an enterprise field sales motion, with marketing conducted at women's health and gynecological medical conferences.
The company's revenue model was based on medical device hardware sales of the Sonata System and related consumables used in radiofrequency fibroid ablation procedures, with pricing conducted on a quote basis through healthcare procurement channels. Gynesonics maintained a European commercial presence, evidenced by a dedicated VP of European Sales & Marketing, and pursued distribution through hospital and health system procurement processes globally. Over its independent lifetime, the company raised approximately $400 million+ across 15+ funding rounds from investors including Abingworth, Bain Capital Life Sciences, Endeavour Vision, HBM Partners, InterWest Partners, Hercules Capital, Advanced Technology Ventures, Amzak Health Investors, Kaiser Permanente Ventures, MVM Life Science Partners, and Runway Growth Capital.
In October 2024, Gynesonics was acquired by Hologic, Inc. for approximately $350 million, integrating the Sonata System into Hologic's GYN Surgical business and broader women's health portfolio. The acquisition expanded Hologic's fibroid treatment offerings within a GYN Surgical franchise that has delivered 7.6% CAGR over the past decade. Post-acquisition, Gynesonics ceased to operate as an independent entity and now functions as a subsidiary or product line under Hologic's corporate umbrella, leveraging Hologic's established global distribution network spanning 36 countries.
Gynesonics firmographics
Firmographics- Name
- Gynesonics
- Legal name
- Gynesonics, Inc.
- Website
- https://gynesonics.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Gynesonics developed the Sonata System, an incisionless transcervical radiofrequency ablation device for treating uterine fibroids and heavy menstrual bleeding. The Redwood City, California medical device company was acquired by Hologic in October 2024 for approximately $350 million.
- Ownership category
- akta.pro rank
Gynesonics industry classification
Industry- Product category
- Women's Health Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)
- akta.pro secondary industries
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Ultrasound & Echography Systems (HLAHABAD)
Keywords
Where Gynesonics is headquartered
LocationHeadquarters
- HQ city
- Redwood City
- HQ country
- United States
- HQ region
- North America
Markets served
Gynesonics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Device Sales: Sale of the Sonata System and related consumables for radiofrequency fibroid treatment procedures in hospitals and outpatient settings
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Gynesonics product offering
Product offeringCore offering
Gynesonics develops and sells the Sonata System, an incisionless, transcervical radiofrequency ablation device used to treat symptomatic uterine fibroids and associated heavy menstrual bleeding. The system combines intrauterine ultrasound guidance with RF ablation to target fibroids without surgical incisions, enabling an outpatient, uterus-preserving alternative to hysterectomy or myomectomy for hospitals, outpatient surgery centers, and gynecologists.
Product overview
Gynesonics is a medical device company that developed the Sonata System, an incisionless radiofrequency ablation platform for treating uterine fibroids and associated heavy menstrual bleeding. The company's flagship product offers a minimally invasive alternative to traditional hysterectomy or myomectomy procedures. Gynesonics was acquired by Hologic in October 2024 for approximately $350 million, expanding Hologic's women's health portfolio with the Sonata System.
Differentiator
Problem solved
Functional benefit
Brands
- Sonata System: Incisionless radiofrequency ablation device for the treatment of uterine fibroids and heavy menstrual bleeding
Products and services
- Sonata System
Companies that use Gynesonics
Customer profileSegments1 record
Ideal customer profiles1 record
Gynesonics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Gynesonics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- HologicflagshipHologic acquired Gynesonics in October 2024 for approximately $350 million to incorporate the Sonata System into Hologic's women's health portfolio. The acquisition expands Hologic's fibroid treatment offerings as part of their GYN Surgical business, which has delivered 7.6% CAGR over the past decade.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Gynesonics competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Gynesonics social profiles
Digital presenceGynesonics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gynesonics leadership team
Management profileNumber of profiles
Profiles7 records
Gynesonics funding detail
Funding detailFunding overview
Funding rounds17 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gynesonics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gynesonics
What does Gynesonics do?
Gynesonics develops and sells the Sonata System, an incisionless, transcervical radiofrequency ablation device used to treat symptomatic uterine fibroids and associated heavy menstrual bleeding. The system combines intrauterine ultrasound guidance with RF ablation to target fibroids without surgical incisions, enabling an outpatient, uterus-preserving alternative to hysterectomy or myomectomy for hospitals, outpatient surgery centers, and gynecologists.
Is Gynesonics a public or private company?
Gynesonics is a private company. It is classified as corporate owned and is currently acquired.
When was Gynesonics founded?
Gynesonics was founded in 2005. It employs 101 to 250 people.
Where is Gynesonics based?
Gynesonics is headquartered in Redwood City, United States, in the North America region.
How does Gynesonics make money?
One revenue line is on record: medical Device Sales.
Does Gynesonics have an API?
No public API is recorded for Gynesonics.
What industry is Gynesonics in?
Gynesonics's product category is Women's Health Medical Devices. Its primary akta.pro industry code is HLAKAJAF, Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy), with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.